The Patent Finder

Sagimet Biosciences Inc.

Also on record
Records under this name other than the patents Sagimet Biosciences Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Back to Sagimet Biosciences Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
14/315,133Heterocyclic Modulators of Lipid Synthesis
Abandoned
Abandoned Mar 14, 2016
AbandonedAbandoned Mar 14, 2016
15/349,960Heterocyclic Modulators of Lipid Synthesis
Abandoned
Abandoned Oct 25, 2018
AbandonedAbandoned Oct 25, 2018
16/157,672Heterocyclic Modulators of Lipid Synthesis
Abandoned
Abandoned Apr 10, 2020
AbandonedAbandoned Apr 10, 2020
17/307,985Heterocyclic Modulators of Lipid Synthesis
Abandoned
Abandoned Feb 12, 2024
AbandonedAbandoned Feb 12, 2024
18/535,291Heterocyclic Modulators of Lipid Synthesis
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/709,271Methods for Prediction of Treatment Response in Non-Alcoholic Fatty Liver Disease
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/749,069Combination Therapies of Fasn Inhibitors with Thyroid Hormone Receptor Agonists
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/490,670Industrial Preparation of Heterocyclic Modulator for Lipid Synthesis
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/504,289Pharmaceutical Composition Containing Heterocyclic Compound
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/527,665Combinations of Fasn Inhibitors and GLP-1 Agonists for Liver Diseases
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 11 records shown.
Pro members see all 11.
Pro members: see all 11 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited